Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
Background: Treatment decisions after diagnosis of clinically localized prostate cancer are difficult due to variability in tumor behavior. As there is a high prevalence of low-grade prostate cancer with an indolent course, we need improved markers of prostate cancer lethality in order to reduce the...
Saved in:
Main Author: | Sumaira Siddiqui |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-04-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijpm.ijpm_171_22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of p53 and Ki67 Expression in Endometrial Cancer and its Effect on Survival
by: Zekiye Sahin, et al.
Published: (2022-03-01) -
Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
by: Shadan Mohamad Omer, et al.
Published: (2020-12-01) -
Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01) -
Multi-institutional evaluation comparing guidance from International Ki67 Working Group vs National Health Commission of China on immunohistochemistry-based Ki67 assessment alongside the Quantitative Dot Blot method
by: Yin Wang, et al.
Published: (2025-01-01) -
Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01)